Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 52 points (0.3%) at 17,129 as of Tuesday, Aug. 26, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,998 issues advancing vs. 975 declining with 164 unchanged. The Health Services industry currently sits up 0.3% versus the S&P 500, which is up 0.2%. Top gainers within the industry include ResMed ( RMD), up 1.4%, Fresenius Medical Care AG & Co. KGaA ( FMS), up 0.9%, Humana ( HUM), up 0.7%, Abbott Laboratories ( ABT), up 0.7% and HCA Holdings ( HCA), up 0.6%. TheStreet would like to highlight 3 stocks pushing the industry higher today: 3. WellPoint ( WLP) is one of the companies pushing the Health Services industry higher today. As of noon trading, WellPoint is up $1.28 (1.1%) to $114.50 on light volume. Thus far, 429,434 shares of WellPoint exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $113.20-$114.88 after having opened the day at $113.55 as compared to the previous trading day's close of $113.22. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. WellPoint, Inc., a health benefits company, through its subsidiaries, provides a range of medical products in the United States. The company offers a spectrum of network-based managed care health benefit plans to large and small employer, individual, Medicaid, and senior markets. WellPoint has a market cap of $31.0 billion and is part of the health care sector. Shares are up 22.6% year-to-date as of the close of trading on Monday. Currently there are 6 analysts who rate WellPoint a buy, no analysts rate it a sell, and 12 rate it a hold. TheStreet Ratings rates WellPoint as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full WellPoint Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.